ESR1 and neoplasm: CD8+ tumor-infiltrating T cells positively associate with survival in triple-negative BC (TNBC) and human epidermal growth factor receptor 2 (HER2/neu) overexpressed (HER2+) BC, but not in estrogen receptor–positive (ER+) BC (4–6).